Cargando…

Evaluation and comparison of intratumoural and intrastromal infiltrating lymphocytes with clinicopathological features in breast carcinoma patients who have received neoadjuvant chemotherapy - A cross-sectional study

BACKGROUND: The microenvironment of breast cancer plays a significant role in determining the prognosis of the disease. With the shifting paradigm on the predictive factors post-Neoadjuvant Chemotherapy (NAC), it was sought out that Tumour infiltrating lymphocytes (TILs) are of valuable use for the...

Descripción completa

Detalles Bibliográficos
Autores principales: Rangan, Rahul, Kanetkar, Sujata R., Bhosale, Suresh J., Kakade, Satish V., Patil, Nanda J., Gudur, Anand
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9422358/
https://www.ncbi.nlm.nih.gov/pubmed/36045840
http://dx.doi.org/10.1016/j.amsu.2022.104308
_version_ 1784777793366654976
author Rangan, Rahul
Kanetkar, Sujata R.
Bhosale, Suresh J.
Kakade, Satish V.
Patil, Nanda J.
Gudur, Anand
author_facet Rangan, Rahul
Kanetkar, Sujata R.
Bhosale, Suresh J.
Kakade, Satish V.
Patil, Nanda J.
Gudur, Anand
author_sort Rangan, Rahul
collection PubMed
description BACKGROUND: The microenvironment of breast cancer plays a significant role in determining the prognosis of the disease. With the shifting paradigm on the predictive factors post-Neoadjuvant Chemotherapy (NAC), it was sought out that Tumour infiltrating lymphocytes (TILs) are of valuable use for the same. Yet, the delineation of the two types - Intrastromal and Intratumoural has seldom been facilitated. This study, therefore, aimed to evaluate, analyse and compare the two - to gauge the importance of the treatment outcome and clinicopathological features. MATERIALS AND METHODS: 180 breast cancer patients were included in this study who underwent NAC, and their post-surgically resected tumour specimens were sectioned and stained using routine Haematoxylin and Eosin techniques. The evaluation of TILs in the stroma and tumour was done based on the standardised guidelines. RESULTS: Out of the 180 patients, 55 (i.e. 30.56%) displayed pathological complete resolution (pCR). Furthermore, Intratumoural TILs had a slight association with the pCR (p = 0.0335) whereas Intrastromal TILs had a significantly large association with pCR (p < 0.0001) dependent on the lymphocytic response. Backward regression revealed that - the age at operation, pCR, lymph node involvement and menopause highly contributed to predicting 68.2% of the total cases correctly with a sensitivity of 93.0% and specificity of 24.6% for Intratumoral TILs. Age at operation, pCR, lymph node involvement and tumour emboli highly contributed to predicting 71.5% of the total cases correctly with sensitivity of 71.6% and specificity of 71.4% for Intrastromal TILs. CONCLUSION: TILs and the prediction of NAC and pCR should be made standardised and reproducible so that they can be universally available to all patients with breast cancer. Through this study, further avenues of research have opened up for their relations with clinicopathological features mainly age at operation and menopausal status.
format Online
Article
Text
id pubmed-9422358
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-94223582022-08-30 Evaluation and comparison of intratumoural and intrastromal infiltrating lymphocytes with clinicopathological features in breast carcinoma patients who have received neoadjuvant chemotherapy - A cross-sectional study Rangan, Rahul Kanetkar, Sujata R. Bhosale, Suresh J. Kakade, Satish V. Patil, Nanda J. Gudur, Anand Ann Med Surg (Lond) Cross-sectional Study BACKGROUND: The microenvironment of breast cancer plays a significant role in determining the prognosis of the disease. With the shifting paradigm on the predictive factors post-Neoadjuvant Chemotherapy (NAC), it was sought out that Tumour infiltrating lymphocytes (TILs) are of valuable use for the same. Yet, the delineation of the two types - Intrastromal and Intratumoural has seldom been facilitated. This study, therefore, aimed to evaluate, analyse and compare the two - to gauge the importance of the treatment outcome and clinicopathological features. MATERIALS AND METHODS: 180 breast cancer patients were included in this study who underwent NAC, and their post-surgically resected tumour specimens were sectioned and stained using routine Haematoxylin and Eosin techniques. The evaluation of TILs in the stroma and tumour was done based on the standardised guidelines. RESULTS: Out of the 180 patients, 55 (i.e. 30.56%) displayed pathological complete resolution (pCR). Furthermore, Intratumoural TILs had a slight association with the pCR (p = 0.0335) whereas Intrastromal TILs had a significantly large association with pCR (p < 0.0001) dependent on the lymphocytic response. Backward regression revealed that - the age at operation, pCR, lymph node involvement and menopause highly contributed to predicting 68.2% of the total cases correctly with a sensitivity of 93.0% and specificity of 24.6% for Intratumoral TILs. Age at operation, pCR, lymph node involvement and tumour emboli highly contributed to predicting 71.5% of the total cases correctly with sensitivity of 71.6% and specificity of 71.4% for Intrastromal TILs. CONCLUSION: TILs and the prediction of NAC and pCR should be made standardised and reproducible so that they can be universally available to all patients with breast cancer. Through this study, further avenues of research have opened up for their relations with clinicopathological features mainly age at operation and menopausal status. Elsevier 2022-08-07 /pmc/articles/PMC9422358/ /pubmed/36045840 http://dx.doi.org/10.1016/j.amsu.2022.104308 Text en © 2022 Published by Elsevier Ltd on behalf of IJS Publishing Group Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Cross-sectional Study
Rangan, Rahul
Kanetkar, Sujata R.
Bhosale, Suresh J.
Kakade, Satish V.
Patil, Nanda J.
Gudur, Anand
Evaluation and comparison of intratumoural and intrastromal infiltrating lymphocytes with clinicopathological features in breast carcinoma patients who have received neoadjuvant chemotherapy - A cross-sectional study
title Evaluation and comparison of intratumoural and intrastromal infiltrating lymphocytes with clinicopathological features in breast carcinoma patients who have received neoadjuvant chemotherapy - A cross-sectional study
title_full Evaluation and comparison of intratumoural and intrastromal infiltrating lymphocytes with clinicopathological features in breast carcinoma patients who have received neoadjuvant chemotherapy - A cross-sectional study
title_fullStr Evaluation and comparison of intratumoural and intrastromal infiltrating lymphocytes with clinicopathological features in breast carcinoma patients who have received neoadjuvant chemotherapy - A cross-sectional study
title_full_unstemmed Evaluation and comparison of intratumoural and intrastromal infiltrating lymphocytes with clinicopathological features in breast carcinoma patients who have received neoadjuvant chemotherapy - A cross-sectional study
title_short Evaluation and comparison of intratumoural and intrastromal infiltrating lymphocytes with clinicopathological features in breast carcinoma patients who have received neoadjuvant chemotherapy - A cross-sectional study
title_sort evaluation and comparison of intratumoural and intrastromal infiltrating lymphocytes with clinicopathological features in breast carcinoma patients who have received neoadjuvant chemotherapy - a cross-sectional study
topic Cross-sectional Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9422358/
https://www.ncbi.nlm.nih.gov/pubmed/36045840
http://dx.doi.org/10.1016/j.amsu.2022.104308
work_keys_str_mv AT ranganrahul evaluationandcomparisonofintratumouralandintrastromalinfiltratinglymphocyteswithclinicopathologicalfeaturesinbreastcarcinomapatientswhohavereceivedneoadjuvantchemotherapyacrosssectionalstudy
AT kanetkarsujatar evaluationandcomparisonofintratumouralandintrastromalinfiltratinglymphocyteswithclinicopathologicalfeaturesinbreastcarcinomapatientswhohavereceivedneoadjuvantchemotherapyacrosssectionalstudy
AT bhosalesureshj evaluationandcomparisonofintratumouralandintrastromalinfiltratinglymphocyteswithclinicopathologicalfeaturesinbreastcarcinomapatientswhohavereceivedneoadjuvantchemotherapyacrosssectionalstudy
AT kakadesatishv evaluationandcomparisonofintratumouralandintrastromalinfiltratinglymphocyteswithclinicopathologicalfeaturesinbreastcarcinomapatientswhohavereceivedneoadjuvantchemotherapyacrosssectionalstudy
AT patilnandaj evaluationandcomparisonofintratumouralandintrastromalinfiltratinglymphocyteswithclinicopathologicalfeaturesinbreastcarcinomapatientswhohavereceivedneoadjuvantchemotherapyacrosssectionalstudy
AT guduranand evaluationandcomparisonofintratumouralandintrastromalinfiltratinglymphocyteswithclinicopathologicalfeaturesinbreastcarcinomapatientswhohavereceivedneoadjuvantchemotherapyacrosssectionalstudy